Primary anticoagulation with bivalirudin for patients with implantable ventricular assist devices

Artificial Organs

Volumn 38, Issue 4, 2014, Pages 342-346

  Pieri, Marina ^a   Agracheva, Natalia ^a   Di Prima, Ambra Licia ^a   Nisi, Teodora ^a   De Bonis, Michele ^a   Isella, Francesca ^a   Zangrillo, Alberto ^a   Pappalardo, Federico ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Anticoagulation; Bivalirudin; Heparin; Ventricular assist device

Indexed keywords

DIAGNOSIS; FIBER OPTIC SENSORS; INTENSIVE CARE UNITS; PATIENT TREATMENT; PLATELETS;

ACTIVATED PARTIAL THROMBOPLASTIN TIME; ANTI-COAGULATION; BIVALIRUDIN; CONTINUOUS INFUSIONS; DIRECT THROMBIN INHIBITOR; MECHANICAL CIRCULATORY SUPPORT; OBSERVATIONAL STUDY; THROMBOCYTOPENIA; UNFRACTIONATED HEPARINS; VENTRICULAR ASSIST DEVICE;

POLYSACCHARIDES;

FIBRINOGEN; HEMOGLOBIN; HEPARIN; HIRULOG; LACTATE DEHYDROGENASE; ANTICOAGULANT AGENT; HIRUDIN DERIVATIVE; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTINUOUS INFUSION; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HOSPITALIZATION; HUMAN; IMPLANTATION; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; LEFT VENTRICULAR ASSIST DEVICE; MALE; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOEMBOLISM; TOTAL ARTIFICIAL HEART; VENTRICULAR ASSIST DEVICE; AGED; CARDIOMYOPATHIES; HEART ASSIST DEVICE; MIDDLE AGED; RETROSPECTIVE STUDY; SHOCK, CARDIOGENIC; TREATMENT OUTCOME;

AGED; ANTICOAGULANTS; CARDIOMYOPATHIES; FEMALE; HEART-ASSIST DEVICES; HIRUDINS; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; TREATMENT OUTCOME;

EID: 84897573638     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/aor.12168     Document Type: Article

References (16)

1. Koster A, Huebler S, Potapov E, etal. Impact of heparin-induced thrombocytopenia on outcome in patients with ventricular assist device support: single-institution experience in 358 consecutive patients. Ann Thorac Surg 2007;83:72-76.
2. Pappalardo F, Scandroglio AM, Potapov E, etal. Argatroban anticoagulation for heparin induced thrombocytopenia in patients with ventricular assist devices. Minerva Anestesiol 2012;78:330-335.
3. Warkentin TE, Greinacher A, Koster A. Bivalirudin. Thromb Haemost 2008;99:830-839.
4. Young E, Prins M, Levine MN, Hirsh J. Heparin binding to plasma proteins, an important mechanism for heparin resistance. Thromb Haemost 1992;67:639-643.
5. Barzu T, Molho P, Tobelem G, Petitou M, Caen J. Binding and endocytosis of heparin by human endothelial cells in culture. Biochim Biophys Acta 1985;845:196-203.
6. Ranucci M, Isgrò G, Cazzaniga A, Soro G, Menicanti L, Frigiola A. Predictors for heparin resistance in patients undergoing coronary artery bypass grafting. Perfusion 1999;14:437-442.
7. Anand SX, Kim MC, Kamran M, etal. Comparison of platelet function and morphology in patients undergoing percutaneous coronary intervention receiving bivalirudin versus unfractionated heparin versus clopidogrel pretreatment and bivalirudin. Am J Cardiol 2007;100:417-424.
8. Mutch NJ, Robbie LA, Booth NA. Human thrombi contain an abundance of active thrombin. Thromb Haemost 2001;86:1028-1034.
9. Weitz JI, Hudoba M, Massel D, Maraganore J, Hirsh J. Clot bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. J Clin Invest 1990;86:385-391.
10. Slaughter MS, Naka Y, John R, etal. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy. J Heart Lung Transplant 2010;29:616-624.
11. Anand SX, Viles-Gonzalez JF, Mahboobi SK, Heerdt PM. Bivalirudin utilization in cardiac surgery: shifting anticoagulation from indirect to direct thrombin inhibition. Can J Anaesth 2011;58:296-311.
12. Rose EA, Gelijns AC, Moskowitz AJ, etal. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345:1435-1443.
13. Frazier OH, Rose EA, Oz MC, etal. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg 2001;122:1186-1195.
14. Starling RC, Naka Y, Boyle AJ, etal. Results of the post-U.S. Food and Drug administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation. J Am Coll Cardiol 2011;57:1890-189.
15. Warkentin TE, Crowther MA. Reversing anticoagulants both old and new. Can J Anaesth 2002;49:S11-25.
16. Pieri M, Agracheva N, Bonaveglio E, etal. Bivalirudin versus heparin as anticoagulant during extracorporeal membrane oxygenation: a case-control study. J Cardiothorac Vasc Anesth 2013;27:30-34.